2024 annual financial data

Vanda Pharmaceuticals 2024 Financial results

Direct answer

Revenue was 198,772,000 USD.

Operating income was -40,660,000 USD and net income was -18,900,000 USD.
Operating cash flow was -15,757,000 USD.

Get free Vanda Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
198,772,000 USD
Operating income
-40,660,000 USD
Net income
-18,900,000 USD
Operating cash flow
-15,757,000 USD